REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmadvance Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Pharmadvance Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

Pharmadvance Kft. is a company based in Hungary, with its head office in Miskolc. The enterprise currently operates in the Pharmacies and Drug Stores sector. Pharmadvance Kft. was incorporated on November 06, 2009. Pharmadvance Kft. currently employs 10 (2024) people. There was a net sales revenue increase of 16.07% reported in Pharmadvance Kft.’s latest financial highlights for 2024. There was a total growth of 10.82% in Pharmadvance Kft.’s total assets over the same period. In 2024, Pharmadvance Kft.’s net profit margin increased by 1.37%.

Headquarters
Kozdomb utca 68.
Miskolc; Borsod-Abauj-Zemplen; Postal Code: 3525

Contact Details: Purchase the Pharmadvance Kft. report to view the information.

Website: http://www.kamillagyogyszertar.hu

Basic Information
Total Employees:
Purchase the Pharmadvance Kft. report to view the information.
Registered Capital:
Purchase the Pharmadvance Kft. report to view the information.
Financial Auditors:
Purchase the Pharmadvance Kft. report to view the information.
Incorporation Date:
November 06, 2009
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pharmadvance Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
16.07%
Total operating revenue
15.96%
Operating profit (EBIT)
26.76%
EBITDA
24.63%
Net Profit (Loss) for the Period
32.64%
Total Assets
10.82%
Total Equity
32.02%
Operating Profit Margin (ROS)
1.04%
Net Profit Margin
1.37%
Return on Equity (ROE)
0.4%
Quick Ratio
0.19%
Cash Ratio
0.43%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?